Evaluation of pulmonary embolism includes assessment of clinical probability and, if indicated, d-dimer testing. Most patients with low-risk pulmonary embolism can be treated with oral anticoagulants.
Funding and Disclosures
Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.
Drs. Kahn and de Wit contributed equally to this article.
This article was updated on July 7, 2022, at NEJM.org.
Print Subscriber? Activate your online access.